原发性肝癌经肝动脉升压化疗栓塞三年随访结果分析

基金项目: 全军医疗卫生科研基金

详细信息

Angiotens Ⅱ in infusion induced hypertension and chemoembolization for primary liver cancer-A clinical analysis of 85 cases w ith 3-year follow-up

摘要: 自1992年5月至1993年4月，对85例原发性肝癌进行肝动脉血管紧张素Ⅱ介导的升压化疗栓塞（IHCE），三年随访结果1年生存率76．4%（65/85），2年生存率48．2%（41/85），3年生存率32．9%（28/85）。文中对IHCE治疗的机理进行探讨，并与TCE相比较。提出IHCE可取代TCE并作为不可切除肝癌的首选疗法。
- 原发性肝癌 /
- 化疗栓塞 /
- 血管紧张素Ⅱ /
- 三年随访
Abstract: Advanced primary liver cancer (PLC) was treatedin 85 cases by Angiotensin Ⅱ infusion induced hypertension and chemoembolization (IHCE) from May 1992 to April 1993. 65 cases(76.4%)have survived more than 1 year, 41 cases(48.2%) survived more than 2 years and 28 cases(32.9%) more than 3 years. IHCE increas-es antitumor effect of TCE, can be the first choice for unresectable PLC instead of TCE.
- Primary liver cancer /
- Angiotensin Ⅱ /
- hypertension and chemoembolization /
- undefined

[1]	姜小清, 等. 血管紧张素Ⅱ介导的肝动脉升压化疗栓塞治疗原发性肝癌的临床研究. 实用肿瘤杂志, 1994, 9: 25.
[2]	陈晓明, 等. 肝庙经导管肝动脉碘油抗癌药混悬剂栓塞后肝脏的延期不良反应. 癌症, 1994, 13: 50.
[3]	苏长青, 等. 血管紧张素, 介导栓塞治疗肝癌的病理观察. 临床与实验病理杂志, 1995, 1: 39.
[4]	姜小清, 等. 血管紧张素, 介导肝动脉升压化疗栓塞中肝脏血流动力学变化. 中华肿瘤杂志, 1994, 11: 647.
[5]	Yamashita Y , et al. Prognostic factors in the treatment of hepatocellular carcinoma with trascatherer arterial embolization and arterial infusion. Cancer, 1991, 67: 385.
[6]	Sasaki Y, et al. New approach of chemoembolzation for hepatocellular carcinoma-Lipidol, cisplantin sand-witch therapy. J Jpn Soc Cancer Ther, 1986, 21: 647.